BioElectronics Corporation
BioElectronics Corporation BIEL Peers
See (BIEL) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIEL | $0.00 | +0.00% | 3.6M | N/A | N/A | N/A |
| SMMNY | $26.84 | +0.45% | 120.6B | 24.84 | $1.08 | +1.10% |
| SEMHF | $54.03 | -1.77% | 60.6B | 24.78 | $2.18 | +1.83% |
| RYLPF | $23.85 | +0.00% | 22.6B | 79.49 | $0.30 | +3.98% |
| SONVY | $58.51 | +1.49% | 17.4B | 25.55 | $2.29 | +1.08% |
| SONVF | $284.75 | -3.04% | 17B | 25.24 | $11.28 | +1.84% |
| CHEOY | $99.85 | +0.08% | 13.1B | 54.27 | $1.84 | +1.40% |
| SNNUF | $14.75 | +0.00% | 12.9B | 31.38 | $0.47 | +2.54% |
| CHEOF | $193.04 | -7.06% | 12.6B | 52.60 | $3.67 | +1.44% |
| WILYY | $20.19 | +0.00% | 9B | 19.41 | $1.04 | N/A |
Stock Comparison
BIEL vs SMMNY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, SMMNY has a market cap of 120.6B. Regarding current trading prices, BIEL is priced at $0.00, while SMMNY trades at $26.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas SMMNY's P/E ratio is 24.84. In terms of profitability, BIEL's ROE is +0.04%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, BIEL is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs SEMHF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, SEMHF has a market cap of 60.6B. Regarding current trading prices, BIEL is priced at $0.00, while SEMHF trades at $54.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas SEMHF's P/E ratio is 24.78. In terms of profitability, BIEL's ROE is +0.04%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, BIEL is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs RYLPF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, RYLPF has a market cap of 22.6B. Regarding current trading prices, BIEL is priced at $0.00, while RYLPF trades at $23.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas RYLPF's P/E ratio is 79.49. In terms of profitability, BIEL's ROE is +0.04%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, BIEL is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs SONVY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, SONVY has a market cap of 17.4B. Regarding current trading prices, BIEL is priced at $0.00, while SONVY trades at $58.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas SONVY's P/E ratio is 25.55. In terms of profitability, BIEL's ROE is +0.04%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, BIEL is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs SONVF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, SONVF has a market cap of 17B. Regarding current trading prices, BIEL is priced at $0.00, while SONVF trades at $284.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas SONVF's P/E ratio is 25.24. In terms of profitability, BIEL's ROE is +0.04%, compared to SONVF's ROE of +0.22%. Regarding short-term risk, BIEL is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs CHEOY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, CHEOY has a market cap of 13.1B. Regarding current trading prices, BIEL is priced at $0.00, while CHEOY trades at $99.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas CHEOY's P/E ratio is 54.27. In terms of profitability, BIEL's ROE is +0.04%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, BIEL is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs SNNUF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, SNNUF has a market cap of 12.9B. Regarding current trading prices, BIEL is priced at $0.00, while SNNUF trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas SNNUF's P/E ratio is 31.38. In terms of profitability, BIEL's ROE is +0.04%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, BIEL is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs CHEOF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, CHEOF has a market cap of 12.6B. Regarding current trading prices, BIEL is priced at $0.00, while CHEOF trades at $193.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas CHEOF's P/E ratio is 52.60. In terms of profitability, BIEL's ROE is +0.04%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, BIEL is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs WILYY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, WILYY has a market cap of 9B. Regarding current trading prices, BIEL is priced at $0.00, while WILYY trades at $20.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas WILYY's P/E ratio is 19.41. In terms of profitability, BIEL's ROE is +0.04%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, BIEL is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs WILLF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, WILLF has a market cap of 8.7B. Regarding current trading prices, BIEL is priced at $0.00, while WILLF trades at $42.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas WILLF's P/E ratio is 20.08. In terms of profitability, BIEL's ROE is +0.04%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, BIEL is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs GNGBY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, GNGBY has a market cap of 5.4B. Regarding current trading prices, BIEL is priced at $0.00, while GNGBY trades at $19.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas GNGBY's P/E ratio is 35.20. In terms of profitability, BIEL's ROE is +0.04%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, BIEL is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs GNGBF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, GNGBF has a market cap of 5.3B. Regarding current trading prices, BIEL is priced at $0.00, while GNGBF trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas GNGBF's P/E ratio is 37.50. In terms of profitability, BIEL's ROE is +0.04%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, BIEL is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs AMBBY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, AMBBY has a market cap of 4.2B. Regarding current trading prices, BIEL is priced at $0.00, while AMBBY trades at $15.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas AMBBY's P/E ratio is 70.05. In terms of profitability, BIEL's ROE is +0.04%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, BIEL is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs AMBFF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, AMBFF has a market cap of 4B. Regarding current trading prices, BIEL is priced at $0.00, while AMBFF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas AMBFF's P/E ratio is 69.09. In terms of profitability, BIEL's ROE is +0.04%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, BIEL is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs NHNKY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, NHNKY has a market cap of 4B. Regarding current trading prices, BIEL is priced at $0.00, while NHNKY trades at $12.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas NHNKY's P/E ratio is 21.34. In terms of profitability, BIEL's ROE is +0.04%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, BIEL is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs NHNKF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, BIEL is priced at $0.00, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, BIEL's ROE is +0.04%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, BIEL is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs GNNDY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, BIEL is priced at $0.00, while GNNDY trades at $46.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas GNNDY's P/E ratio is 17.87. In terms of profitability, BIEL's ROE is +0.04%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, BIEL is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs MCRPF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, MCRPF has a market cap of 2.2B. Regarding current trading prices, BIEL is priced at $0.00, while MCRPF trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas MCRPF's P/E ratio is -9.92. In terms of profitability, BIEL's ROE is +0.04%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, BIEL is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs GGNDF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, BIEL is priced at $0.00, while GGNDF trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas GGNDF's P/E ratio is 16.72. In terms of profitability, BIEL's ROE is +0.04%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, BIEL is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs STSEY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, BIEL is priced at $0.00, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas STSEY's P/E ratio is 39.41. In terms of profitability, BIEL's ROE is +0.04%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, BIEL is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs VTRLY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, BIEL is priced at $0.00, while VTRLY trades at $14.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas VTRLY's P/E ratio is 44.06. In terms of profitability, BIEL's ROE is +0.04%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, BIEL is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs OSSFF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, BIEL is priced at $0.00, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, BIEL's ROE is +0.04%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, BIEL is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs DWRKF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, BIEL is priced at $0.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, BIEL's ROE is +0.04%, compared to DWRKF's ROE of N/A. Regarding short-term risk, BIEL is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs OSSUY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, BIEL is priced at $0.00, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, BIEL's ROE is +0.04%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, BIEL is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs MEDGF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, BIEL is priced at $0.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, BIEL's ROE is +0.04%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, BIEL is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs DRWKF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, BIEL is priced at $0.00, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas DRWKF's P/E ratio is 9.40. In terms of profitability, BIEL's ROE is +0.04%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, BIEL is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs DGWPF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, BIEL is priced at $0.00, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas DGWPF's P/E ratio is 8.02. In terms of profitability, BIEL's ROE is +0.04%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, BIEL is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs LFTSF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, BIEL is priced at $0.00, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, BIEL's ROE is +0.04%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, BIEL is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs ELEAF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, ELEAF has a market cap of 1B. Regarding current trading prices, BIEL is priced at $0.00, while ELEAF trades at $12.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas ELEAF's P/E ratio is 14.55. In terms of profitability, BIEL's ROE is +0.04%, compared to ELEAF's ROE of +0.15%. Regarding short-term risk, BIEL is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs MDRSF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, MDRSF has a market cap of 828.1M. Regarding current trading prices, BIEL is priced at $0.00, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, BIEL's ROE is +0.04%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, BIEL is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs XVIPF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, XVIPF has a market cap of 693M. Regarding current trading prices, BIEL is priced at $0.00, while XVIPF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas XVIPF's P/E ratio is 48.89. In terms of profitability, BIEL's ROE is +0.04%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, BIEL is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs CALZF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, CALZF has a market cap of 525M. Regarding current trading prices, BIEL is priced at $0.00, while CALZF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas CALZF's P/E ratio is 76.00. In terms of profitability, BIEL's ROE is +0.04%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, BIEL is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs AVMR Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, BIEL is priced at $0.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas AVMR's P/E ratio is -18.34. In terms of profitability, BIEL's ROE is +0.04%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, BIEL is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs CLVSF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, CLVSF has a market cap of 459.8M. Regarding current trading prices, BIEL is priced at $0.00, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, BIEL's ROE is +0.04%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, BIEL is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs IOBCF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, IOBCF has a market cap of 414.5M. Regarding current trading prices, BIEL is priced at $0.00, while IOBCF trades at $14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas IOBCF's P/E ratio is 39.31. In terms of profitability, BIEL's ROE is +0.04%, compared to IOBCF's ROE of +0.09%. Regarding short-term risk, BIEL is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs CSSPF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, CSSPF has a market cap of 384M. Regarding current trading prices, BIEL is priced at $0.00, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, BIEL's ROE is +0.04%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, BIEL is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs HYBT Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, BIEL is priced at $0.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas HYBT's P/E ratio is N/A. In terms of profitability, BIEL's ROE is +0.04%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, BIEL is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs EAPIF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, EAPIF has a market cap of 347.6M. Regarding current trading prices, BIEL is priced at $0.00, while EAPIF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas EAPIF's P/E ratio is -2.27. In terms of profitability, BIEL's ROE is +0.04%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, BIEL is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs CYBQY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, CYBQY has a market cap of 335.6M. Regarding current trading prices, BIEL is priced at $0.00, while CYBQY trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas CYBQY's P/E ratio is -70.50. In terms of profitability, BIEL's ROE is +0.04%, compared to CYBQY's ROE of -0.01%. Regarding short-term risk, BIEL is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs BRSYF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, BRSYF has a market cap of 256.2M. Regarding current trading prices, BIEL is priced at $0.00, while BRSYF trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas BRSYF's P/E ratio is 61.64. In terms of profitability, BIEL's ROE is +0.04%, compared to BRSYF's ROE of +0.07%. Regarding short-term risk, BIEL is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs CLLKF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, CLLKF has a market cap of 245.2M. Regarding current trading prices, BIEL is priced at $0.00, while CLLKF trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas CLLKF's P/E ratio is -7.89. In terms of profitability, BIEL's ROE is +0.04%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, BIEL is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs HTLZF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, BIEL is priced at $0.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, BIEL's ROE is +0.04%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, BIEL is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs BCCOY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, BCCOY has a market cap of 221M. Regarding current trading prices, BIEL is priced at $0.00, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, BIEL's ROE is +0.04%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, BIEL is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs IMPZY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, IMPZY has a market cap of 199.9M. Regarding current trading prices, BIEL is priced at $0.00, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, BIEL's ROE is +0.04%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, BIEL is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs PXMBF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, PXMBF has a market cap of 184.6M. Regarding current trading prices, BIEL is priced at $0.00, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, BIEL's ROE is +0.04%, compared to PXMBF's ROE of +0.12%. Regarding short-term risk, BIEL is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs DTXMF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, BIEL is priced at $0.00, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, BIEL's ROE is +0.04%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, BIEL is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for BIEL.
BIEL vs CYBQF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, CYBQF has a market cap of 163.5M. Regarding current trading prices, BIEL is priced at $0.00, while CYBQF trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas CYBQF's P/E ratio is -61.25. In terms of profitability, BIEL's ROE is +0.04%, compared to CYBQF's ROE of -0.01%. Regarding short-term risk, BIEL is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs EKDHF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, EKDHF has a market cap of 157.2M. Regarding current trading prices, BIEL is priced at $0.00, while EKDHF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas EKDHF's P/E ratio is 17.50. In terms of profitability, BIEL's ROE is +0.04%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, BIEL is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs AVHHL Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, AVHHL has a market cap of 137.7M. Regarding current trading prices, BIEL is priced at $0.00, while AVHHL trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas AVHHL's P/E ratio is -3.07. In terms of profitability, BIEL's ROE is +0.04%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, BIEL is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs AMEUF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, BIEL is priced at $0.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, BIEL's ROE is +0.04%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, BIEL is more volatile compared to AMEUF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs VMTHF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, VMTHF has a market cap of 110M. Regarding current trading prices, BIEL is priced at $0.00, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, BIEL's ROE is +0.04%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, BIEL is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs JMDMF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, JMDMF has a market cap of 104.4M. Regarding current trading prices, BIEL is priced at $0.00, while JMDMF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, BIEL's ROE is +0.04%, compared to JMDMF's ROE of N/A. Regarding short-term risk, BIEL is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs IPDQF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, IPDQF has a market cap of 104.2M. Regarding current trading prices, BIEL is priced at $0.00, while IPDQF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas IPDQF's P/E ratio is -5.14. In terms of profitability, BIEL's ROE is +0.04%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, BIEL is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs RSHUF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, BIEL is priced at $0.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, BIEL's ROE is +0.04%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, BIEL is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for BIEL.
BIEL vs SOMNF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, SOMNF has a market cap of 90.8M. Regarding current trading prices, BIEL is priced at $0.00, while SOMNF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas SOMNF's P/E ratio is -14.00. In terms of profitability, BIEL's ROE is +0.04%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, BIEL is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs SNZZF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, SNZZF has a market cap of 89.4M. Regarding current trading prices, BIEL is priced at $0.00, while SNZZF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas SNZZF's P/E ratio is -5.69. In terms of profitability, BIEL's ROE is +0.04%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, BIEL is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs CKMTF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, BIEL is priced at $0.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, BIEL's ROE is +0.04%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, BIEL is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs DMTRF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, DMTRF has a market cap of 76.1M. Regarding current trading prices, BIEL is priced at $0.00, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, BIEL's ROE is +0.04%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, BIEL is more volatile compared to DMTRF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs FDMDF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, FDMDF has a market cap of 75.7M. Regarding current trading prices, BIEL is priced at $0.00, while FDMDF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas FDMDF's P/E ratio is -2.03. In terms of profitability, BIEL's ROE is +0.04%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, BIEL is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs RDGL Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, RDGL has a market cap of 62.1M. Regarding current trading prices, BIEL is priced at $0.00, while RDGL trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas RDGL's P/E ratio is -13.70. In terms of profitability, BIEL's ROE is +0.04%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, BIEL is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs BLOZF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, BLOZF has a market cap of 53M. Regarding current trading prices, BIEL is priced at $0.00, while BLOZF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas BLOZF's P/E ratio is -23.00. In terms of profitability, BIEL's ROE is +0.04%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, BIEL is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs BRNHF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, BRNHF has a market cap of 42.2M. Regarding current trading prices, BIEL is priced at $0.00, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, BIEL's ROE is +0.04%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, BIEL is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs NVYTF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, NVYTF has a market cap of 38.9M. Regarding current trading prices, BIEL is priced at $0.00, while NVYTF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas NVYTF's P/E ratio is -0.74. In terms of profitability, BIEL's ROE is +0.04%, compared to NVYTF's ROE of +0.00%. Regarding short-term risk, BIEL is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs TLTFF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, TLTFF has a market cap of 35.6M. Regarding current trading prices, BIEL is priced at $0.00, while TLTFF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas TLTFF's P/E ratio is -14.21. In terms of profitability, BIEL's ROE is +0.04%, compared to TLTFF's ROE of -2.57%. Regarding short-term risk, BIEL is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs ELXMF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, BIEL is priced at $0.00, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, BIEL's ROE is +0.04%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, BIEL is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs MKEAF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, BIEL is priced at $0.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, BIEL's ROE is +0.04%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, BIEL is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs EMITF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, EMITF has a market cap of 24.6M. Regarding current trading prices, BIEL is priced at $0.00, while EMITF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas EMITF's P/E ratio is -12.33. In terms of profitability, BIEL's ROE is +0.04%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, BIEL is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs KBBTF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, BIEL is priced at $0.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, BIEL's ROE is +0.04%, compared to KBBTF's ROE of N/A. Regarding short-term risk, BIEL is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs POSC Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, POSC has a market cap of 21.6M. Regarding current trading prices, BIEL is priced at $0.00, while POSC trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas POSC's P/E ratio is 0.37. In terms of profitability, BIEL's ROE is +0.04%, compared to POSC's ROE of +9.25%. Regarding short-term risk, BIEL is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs MDXHF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, MDXHF has a market cap of 19.8M. Regarding current trading prices, BIEL is priced at $0.00, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, BIEL's ROE is +0.04%, compared to MDXHF's ROE of +0.49%. Regarding short-term risk, BIEL is less volatile compared to MDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIEL.
BIEL vs ASAPF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, ASAPF has a market cap of 19.7M. Regarding current trading prices, BIEL is priced at $0.00, while ASAPF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas ASAPF's P/E ratio is -25.30. In terms of profitability, BIEL's ROE is +0.04%, compared to ASAPF's ROE of -0.23%. Regarding short-term risk, BIEL is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs GTHP Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, GTHP has a market cap of 18.5M. Regarding current trading prices, BIEL is priced at $0.00, while GTHP trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas GTHP's P/E ratio is -4.70. In terms of profitability, BIEL's ROE is +0.04%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, BIEL is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs PYNKF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, PYNKF has a market cap of 18.1M. Regarding current trading prices, BIEL is priced at $0.00, while PYNKF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas PYNKF's P/E ratio is -0.87. In terms of profitability, BIEL's ROE is +0.04%, compared to PYNKF's ROE of -1.58%. Regarding short-term risk, BIEL is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs DIZTF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, BIEL is priced at $0.00, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, BIEL's ROE is +0.04%, compared to DIZTF's ROE of -2.22%. Regarding short-term risk, BIEL is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs VPTDF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, VPTDF has a market cap of 17.8M. Regarding current trading prices, BIEL is priced at $0.00, while VPTDF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas VPTDF's P/E ratio is -5.32. In terms of profitability, BIEL's ROE is +0.04%, compared to VPTDF's ROE of +1.70%. Regarding short-term risk, BIEL is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs TMDIF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, BIEL is priced at $0.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, BIEL's ROE is +0.04%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, BIEL is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for BIEL.
BIEL vs PLLWF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, PLLWF has a market cap of 13.3M. Regarding current trading prices, BIEL is priced at $0.00, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, BIEL's ROE is +0.04%, compared to PLLWF's ROE of -0.61%. Regarding short-term risk, BIEL is more volatile compared to PLLWF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs RMSL Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, RMSL has a market cap of 12.4M. Regarding current trading prices, BIEL is priced at $0.00, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas RMSL's P/E ratio is 0.81. In terms of profitability, BIEL's ROE is +0.04%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, BIEL is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs IMEXF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, IMEXF has a market cap of 11.9M. Regarding current trading prices, BIEL is priced at $0.00, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas IMEXF's P/E ratio is N/A. In terms of profitability, BIEL's ROE is +0.04%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, BIEL is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for BIEL.
BIEL vs ATBPF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, BIEL is priced at $0.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, BIEL's ROE is +0.04%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, BIEL is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs LXXGF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, BIEL is priced at $0.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, BIEL's ROE is +0.04%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, BIEL is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs NGMDF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, NGMDF has a market cap of 8.5M. Regarding current trading prices, BIEL is priced at $0.00, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas NGMDF's P/E ratio is -3.74. In terms of profitability, BIEL's ROE is +0.04%, compared to NGMDF's ROE of +0.36%. Regarding short-term risk, BIEL is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs FZMD Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, FZMD has a market cap of 7.4M. Regarding current trading prices, BIEL is priced at $0.00, while FZMD trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas FZMD's P/E ratio is 2.00. In terms of profitability, BIEL's ROE is +0.04%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, BIEL is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs ALRTF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, ALRTF has a market cap of 6.4M. Regarding current trading prices, BIEL is priced at $0.00, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas ALRTF's P/E ratio is -0.33. In terms of profitability, BIEL's ROE is +0.04%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, BIEL is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs QLIS Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, BIEL is priced at $0.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas QLIS's P/E ratio is 2.22. In terms of profitability, BIEL's ROE is +0.04%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, BIEL is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs RHNMF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, BIEL is priced at $0.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, BIEL's ROE is +0.04%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, BIEL is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs LBLTF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, BIEL is priced at $0.00, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, BIEL's ROE is +0.04%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, BIEL is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for BIEL.
BIEL vs NUMD Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, NUMD has a market cap of 4M. Regarding current trading prices, BIEL is priced at $0.00, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas NUMD's P/E ratio is 4.73. In terms of profitability, BIEL's ROE is +0.04%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, BIEL is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs ADMT Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, ADMT has a market cap of 3.7M. Regarding current trading prices, BIEL is priced at $0.00, while ADMT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas ADMT's P/E ratio is -5.45. In terms of profitability, BIEL's ROE is +0.04%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, BIEL is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs ODYY Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, ODYY has a market cap of 3.5M. Regarding current trading prices, BIEL is priced at $0.00, while ODYY trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas ODYY's P/E ratio is -0.24. In terms of profitability, BIEL's ROE is +0.04%, compared to ODYY's ROE of +2.30%. Regarding short-term risk, BIEL is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for BIEL.
BIEL vs PMEDF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, PMEDF has a market cap of 3.5M. Regarding current trading prices, BIEL is priced at $0.00, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas PMEDF's P/E ratio is -1.80. In terms of profitability, BIEL's ROE is +0.04%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, BIEL is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs VANIW Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, BIEL is priced at $0.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas VANIW's P/E ratio is N/A. In terms of profitability, BIEL's ROE is +0.04%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, BIEL is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for BIEL.
BIEL vs VYCO Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, VYCO has a market cap of 3.3M. Regarding current trading prices, BIEL is priced at $0.00, while VYCO trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas VYCO's P/E ratio is -10.00. In terms of profitability, BIEL's ROE is +0.04%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, BIEL is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs TBRIF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, TBRIF has a market cap of 2.9M. Regarding current trading prices, BIEL is priced at $0.00, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas TBRIF's P/E ratio is -0.77. In terms of profitability, BIEL's ROE is +0.04%, compared to TBRIF's ROE of -2.28%. Regarding short-term risk, BIEL is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for BIEL.
BIEL vs ESMC Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, ESMC has a market cap of 2.5M. Regarding current trading prices, BIEL is priced at $0.00, while ESMC trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas ESMC's P/E ratio is 6.87. In terms of profitability, BIEL's ROE is +0.04%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, BIEL is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs IRME Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, IRME has a market cap of 2.2M. Regarding current trading prices, BIEL is priced at $0.00, while IRME trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas IRME's P/E ratio is -1.00. In terms of profitability, BIEL's ROE is +0.04%, compared to IRME's ROE of +11.77%. Regarding short-term risk, BIEL is more volatile compared to IRME. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs USAQ Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, USAQ has a market cap of 2M. Regarding current trading prices, BIEL is priced at $0.00, while USAQ trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas USAQ's P/E ratio is -4.50. In terms of profitability, BIEL's ROE is +0.04%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, BIEL is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs UAHC Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, UAHC has a market cap of 1.6M. Regarding current trading prices, BIEL is priced at $0.00, while UAHC trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas UAHC's P/E ratio is 0.57. In terms of profitability, BIEL's ROE is +0.04%, compared to UAHC's ROE of +0.07%. Regarding short-term risk, BIEL is more volatile compared to UAHC. This indicates potentially higher risk in terms of short-term price fluctuations for BIEL.
BIEL vs CRRVF Comparison
BIEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIEL stands at 3.6M. In comparison, CRRVF has a market cap of 1.5M. Regarding current trading prices, BIEL is priced at $0.00, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIEL currently has a P/E ratio of N/A, whereas CRRVF's P/E ratio is N/A. In terms of profitability, BIEL's ROE is +0.04%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, BIEL is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for BIEL.